Cyclerion Therapeutics, Inc.
-
Ticker
CYCN
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Cambridge, Massachusetts
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Lead programs include its vascular-targeted olinciguat in Phase 2 development for sickle cell disease and IW-6463, a pioneering CNS-penetrant sGC stimulator in clinical development for
…More Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes (MELAS) and Alzheimer's Disease with Vascular pathology (ADv)
REPORT RATINGS
4.8 / 5.0 (121)
Cyclerion Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 121 reviews.
Cyclerion Therapeutics, Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports